QVIDCO Trademark

Trademark Overview

On Monday, August 3, 2020, a trademark application was filed for QVIDCO with the United States Patent and Trademark Office. The USPTO has given the QVIDCO trademark a serial number of 90089052. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 8, 2024. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The QVIDCO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders
qvidco

General Information

Serial Number90089052
Word MarkQVIDCO
Filing DateMonday, August 3, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 13, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 2, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Monday, January 8, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 8, 2024ABANDONMENT - NO USE STATEMENT FILED
Saturday, May 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 12, 2023SOU EXTENSION 5 GRANTED
Monday, May 8, 2023SOU EXTENSION 5 FILED
Friday, May 12, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 8, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 11, 2022SOU EXTENSION 4 GRANTED
Friday, November 11, 2022SOU EXTENSION 4 FILED
Friday, November 11, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 10, 2022SOU EXTENSION 3 GRANTED
Tuesday, May 10, 2022SOU EXTENSION 3 FILED
Tuesday, May 10, 2022SOU TEAS EXTENSION RECEIVED
Thursday, November 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 9, 2021SOU EXTENSION 2 GRANTED
Tuesday, November 9, 2021SOU EXTENSION 2 FILED
Tuesday, November 9, 2021SOU TEAS EXTENSION RECEIVED
Friday, May 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 12, 2021SOU EXTENSION 1 GRANTED
Wednesday, May 12, 2021SOU EXTENSION 1 FILED
Wednesday, May 12, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, December 8, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 13, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 13, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 23, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 10, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 8, 2020ASSIGNED TO EXAMINER
Tuesday, September 8, 2020PETITION TO DIRECTOR GRANTED
Friday, September 4, 2020ASSIGNED TO PETITION STAFF
Wednesday, September 2, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 31, 2020TEAS PETITION TO DIRECTOR RECEIVED
Thursday, August 6, 2020NEW APPLICATION ENTERED

Related Keywords

qvidco respiratory diseases disorders disease coronavirus treatment prevention covid antivirals preparations